Table 2.
Clinicopathologic characteristics of patients and lesions.
| Feature | Value |
|---|---|
| Patients (n = 16) | |
| Mean patient age in years (SD) | 51.1 (13.5) |
| Menopausal status | |
| Pre-menopausal | 8 (50%) |
| Post-menopausal | 8 (50%) |
| Breast type | |
| Almost entirely fatty | 1 (6.25%) |
| Scattered FGT | 3 (18.25%) |
| Heterogeneous FGT | 8 (50%) |
| Extreme FGT | 4 (25%) |
| Breast tumors (n = 16) | |
| Size in mm (SD) | 30 (17.5) |
| Lesion type on DCE-MRI | |
| Mass | 12 (75%) |
| NME | 2 (12.5%) |
| Mixed | 2 (12.5%) |
| Histopathology | |
| IDC | 8 (50%) |
| ILC | 1 (6.25%) |
| DCIS | 2 (12.5%) |
| IDCs with extensive DCIS component | 5 (31.25%) |
Abbreviations: DCE-MRI, dynamic contrast-enhanced magnetic resonance imaging; DCIS, ductal carcinoma in situ; FGT, fibroglandular tissue; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; n, number; NME, non-mass-enhancing lesion; SD, standard deviation.